• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[单纯疱疹病毒2型糖蛋白D重组腺病毒疫苗的构建及免疫原性分析]

[Construction and Immunogenicity Analysis of Herpes Simplex Virus Type 2 Glycoprotein D Recombinant Adenovirus Vaccine].

作者信息

Liu Wei, Zhao Donghai, Wang Ziyan, Li Yan, Wang Hao, Wang Huiyan

出版信息

Bing Du Xue Bao. 2016 May;32(3):267-72.

PMID:29962197
Abstract

Herpes simplex virus 2 (HSV-2) is the main pathogen of genital herpes (GH).The currently available body of evidence suggests that only widespread use of an effective vaccine can control the spread of HSV-2.We developed a recombinant replication-defective adenovirus capable of expressing glycoprotein D2(rAd-gD2), and was identified by PCR and Western blot in gene and protein level, respectively. The mice in test groups were immunized intramuscularly (i.m.) with rAd-gD2 in 0and 4 week,while control mice received PBS and AdV. We detected gD2 IgG antibody and neutralizing antibody in order to evaluate of humoral immune response, detected Th1 (IL-2 and IFN-γ)/Th2 (IL-4, IL-5 and IL-10) cytokines in order to evaluate of cellular immune response. The results showed that immunization with rAd-gD2 could elicit strong gD2IgG(P<0.01)and neutralizing antibody levels(P<0.05),which were significantly higher than that with PBS and AdV groups IL-2IFN-γIL-4IL-5 and IL-10 detected in rAd-gD2 group were higher than control groups (P<0.01), Th1/Th2 cytokines were important standard of cellular/humoral immune response, respectively. The results demonstrated that rAd-gD2 could stimulate not only humoral immune response but also cellular immune response, rAd-gD2 may be good candidate for the control of HSV-2infection.

摘要

单纯疱疹病毒2型(HSV-2)是生殖器疱疹(GH)的主要病原体。目前可得的证据表明,只有广泛使用有效的疫苗才能控制HSV-2的传播。我们构建了一种能够表达糖蛋白D2的重组复制缺陷型腺病毒(rAd-gD2),并分别通过PCR和蛋白质印迹在基因和蛋白质水平进行了鉴定。实验组小鼠在第0周和第4周通过肌肉注射(i.m.)rAd-gD2进行免疫,而对照小鼠接受PBS和腺病毒载体(AdV)。我们检测了gD2 IgG抗体和中和抗体以评估体液免疫反应,检测了Th1(IL-2和IFN-γ)/Th2(IL-4、IL-5和IL-10)细胞因子以评估细胞免疫反应。结果表明,用rAd-gD2免疫可引发强烈的gD2 IgG(P<0.01)和中和抗体水平(P<0.05),显著高于PBS和AdV组。在rAd-gD2组中检测到的IL-2、IFN-γ、IL-4、IL-5和IL-10高于对照组(P<0.01),Th1/Th2细胞因子分别是细胞/体液免疫反应的重要指标。结果表明,rAd-gD2不仅能刺激体液免疫反应,还能刺激细胞免疫反应,rAd-gD2可能是控制HSV-2感染的良好候选物。

相似文献

1
[Construction and Immunogenicity Analysis of Herpes Simplex Virus Type 2 Glycoprotein D Recombinant Adenovirus Vaccine].[单纯疱疹病毒2型糖蛋白D重组腺病毒疫苗的构建及免疫原性分析]
Bing Du Xue Bao. 2016 May;32(3):267-72.
2
A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens.一种双模态单纯疱疹病毒2型疫苗,通过使用糖蛋白C和D亚基抗原诱导强效抗体反应以及包含衣壳和被膜蛋白的腺病毒载体作为T细胞免疫原,用于预防生殖器疱疹。
J Virol. 2015 Aug;89(16):8497-509. doi: 10.1128/JVI.01089-15. Epub 2015 Jun 3.
3
Immunogenicity, protective efficacy, and non-replicative status of the HSV-2 vaccine candidate HSV529 in mice and guinea pigs.单纯疱疹病毒2型候选疫苗HSV529在小鼠和豚鼠体内的免疫原性、保护效力及非复制状态
PLoS One. 2015 Apr 2;10(4):e0121518. doi: 10.1371/journal.pone.0121518. eCollection 2015.
4
Evaluation of recombinant adenovirus vaccines based on glycoprotein D and truncated UL25 against herpes simplex virus type 2 in mice.基于糖蛋白D和截短型UL25的重组腺病毒疫苗对小鼠2型单纯疱疹病毒的评估。
Microbiol Immunol. 2017 May;61(5):176-184. doi: 10.1111/1348-0421.12482.
5
Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes.阻断单纯疱疹病毒 2 糖蛋白 E 的免疫逃逸作用以增强三价亚单位抗原疫苗治疗生殖器疱疹的疗效。
J Virol. 2014 Aug;88(15):8421-32. doi: 10.1128/JVI.01130-14. Epub 2014 May 14.
6
Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine.接受葛兰素史克 HSV-2 糖蛋白 D2 亚单位疫苗的个体产生的抗体对单纯疱疹病毒 1 型(HSV-1)的中和作用优于 HSV-2。
J Infect Dis. 2014 Aug 15;210(4):571-5. doi: 10.1093/infdis/jiu177. Epub 2014 Mar 20.
7
Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection.Vaxfectin 佐剂质粒 DNA 疫苗可改善生殖器疱疹感染小鼠模型的保护效果和免疫原性。
J Gen Virol. 2012 Jun;93(Pt 6):1305-1315. doi: 10.1099/vir.0.040055-0. Epub 2012 Mar 7.
8
Expression of the herpes simplex virus type 2 glycoprotein D in baculovirus expression system and evaluation of its immunogenicity in guinea pigs.2型单纯疱疹病毒糖蛋白D在杆状病毒表达系统中的表达及其在豚鼠体内免疫原性的评估。
Iran Biomed J. 2008 Apr;12(2):59-66.
9
Effects of DNA immunization formulated with bupivacaine in murine and guinea pig models of genital herpes simplex virus infection.布比卡因配制的DNA免疫在单纯疱疹病毒生殖器感染的小鼠和豚鼠模型中的作用
Vaccine. 1999 Apr 9;17(15-16):1964-9. doi: 10.1016/s0264-410x(98)00469-1.
10
Development of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in mice.开发一种表达糖蛋白 D 的显性负突变和复制缺陷单纯疱疹病毒 2(HSV-2)重组病毒疫苗,以预防小鼠的 HSV-2 感染。
J Virol. 2011 May;85(10):5036-47. doi: 10.1128/JVI.02548-10. Epub 2011 Mar 9.